UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000042511
Receipt No. R000048109
Scientific Title Usefulness of zinc preparation administration in zinc deficiency dialysis patients
Date of disclosure of the study information 2021/06/30
Last modified on 2020/11/20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Usefulness of zinc preparation administration in zinc deficiency dialysis patients
Acronym Usefulness of zinc preparation administration in zinc deficiency dialysis patients
Scientific Title Usefulness of zinc preparation administration in zinc deficiency dialysis patients
Scientific Title:Acronym Usefulness of zinc preparation administration in zinc deficiency dialysis patients
Region
Japan

Condition
Condition Zinc deficiency
Latent zinc deficiency
Classification by specialty
Nephrology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 At our hospital, zinc acetate hydrate preparation, which is a therapeutic drug for zinc deficiency, is not adopted in the hospital, but polar prezinc orally disintegrating tablets are adopted.
As zinc, zinc acetate hydrate preparations can be administered up to 150 mg / day, while poraprezinc orally disintegrating tablets can only be administered up to 34 mg / day.
Since active solute removal is performed under the OHDF treatment conditions of this hospital, the dose of ESA preparation is reduced and anemia is improved in OHDF patients and patients who administer poraprezinc orally disintegrating tablets, or administration of poraprezinc orally disintegrating tablets. Considering the effects of the amount and iron-containing preparations, we will compare and examine each albumin leakage amount under dialysis treatment conditions.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Others
Developmental phase Not applicable

Assessment
Primary outcomes Serum zinc concentration
ESA dose
Hb
Albumin leakage
Key secondary outcomes age
Dialysis history
Dialysis conditions
Dialysate
TSAT
Ferritin
Fedin administration period
Ferromia oral dose
Riona oral dose
Pettle dose
Total zinc dose
TP
Correction Ca
P
PTH
K
Mg
Kt/V
Beta 2 microglobulin
HS-CRP
Cr index
Serum Alb
nPCR
ERI
Lipid

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with deficiency or latent deficiency measured for serum zinc levels
Key exclusion criteria Patients receiving zinc preparations before the start of evaluation
Patients who discontinued administration after exceeding the doctor's judgment and serum zinc concentration standard value
Patients receiving more than the package insert of Polarezinc Orally Disintegrating Tablets
Target sample size 100

Research contact person
Name of lead principal investigator
1st name Ryosuke
Middle name
Last name Hatonari
Organization Kawashima Hospital Group
Division name Faculty of Clinical Engineering
Zip code 770-0011
Address 6-1 Kitasako 1bancho, Tokushima City, Tokushima Prefecture
TEL 088-634-0200
Email r.hatonari@khg.or.jp

Public contact
Name of contact person
1st name Ryosuke
Middle name
Last name Hatonari
Organization Kawashima Hospital Group
Division name Faculty of Clinical Engineering
Zip code 770-0011
Address 1-39 Kitasako 1bancho, Tokushima City, Tokushima Prefecture
TEL 088-631-0110
Homepage URL
Email r.hatonari@khg.or.jp

Sponsor
Institute Kawashima Hospital Group
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Kawashima Hospital Group
Address 1-39 Kitasako 1bancho, Tokushima City, Tokushima Prefecture
Tel 088-631-0110
Email r.hatonari@khg.or.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 川島透析クリニック(徳島県)

Other administrative information
Date of disclosure of the study information
2021 Year 06 Month 30 Day

Related information
URL releasing protocol
Publication of results Partially published

Result
URL related to results and publications
Number of participants that the trial has enrolled 100
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2020 Year 07 Month 14 Day
Date of IRB
2020 Year 07 Month 21 Day
Anticipated trial start date
2020 Year 10 Month 19 Day
Last follow-up date
2021 Year 06 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Zinc deficiency was suspected in a patient undergoing OHDF at our hospital, and blood zinc concentration was measured from January 2017 to May 2020. Zinc deficiency and latent zinc deficiency were diagnosed as dysgeusia. Patients who received internally disintegrating tablets will be evaluated before zinc administration, 6 months after administration, and 1 year after administration.

Management information
Registered date
2020 Year 11 Month 20 Day
Last modified on
2020 Year 11 Month 20 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048109

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.